Neurociencias e innovación

A Spanish family with a compound heterozygous mutation in SPG7: From uncertainty to clinical reality

Cautionary note on the use of Caenorhabditis elegans to study muscle phenotypes caused by mutations in the human MYH7 gene

Consensus document for the training of residents in cardiovascular risk

Critical limb ischemia in the very elderly patients: A growing problem

Has the paradigm of stroke prevention changed in patients with diabetes?

HeterozygousCAPN3missense variants causing autosomal-dominant calpainopathy in seven unrelated families

Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?

Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives

In stroke patients, lower LDL-cholesterol is actually better

Intracranial calcifications associated with epilepsy: A case report of lipoid proteinosis

Lacosamide intake during pregnancy increases the incidence of foetal malformations and symptoms associated with schizophrenia in the offspring of mice

Neurology during the pandemic. Is COVID-19 changing the organisation of Neurology Departments?

Pharmacological management of post-stroke depression

Secondary stroke prevention in patients with type 2 diabetes. Is time for more specific recommendations?

Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group

Usefulness of predictive models of pulmonary embolism

Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey

A novel MYH7 founder mutation causing Laing distal myopathy in Southern Spain.

Antidiabetic drugs and stroke risk. Current evidence.

Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.

Complications after superficial parotidectomy for pleomorphic adenoma

How and when to refer patients diagnosed with secondary headache and other craniofacial pain in the Emergency Department and Primary Care: Recommendations of the Spanish Society of Neurology's Headache Study Group.

OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study

Satisfaction with oral anticoagulants in patients with atrial fibrillation

The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.

Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: the ESPARTA study.

Update concept of the dual blocking of the renin-angiotensin-aldosteron system. A new therapeutic option?

Adherence to recommendations of the Therapeutic Positioning Report about treatment with oral anticoagulants in elderly patients with atrial fibrillation. The ESPARTA study.

Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study.

Cholesterol and stroke: Roll of PCSK9 inhibitors.

Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain.

EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.

Endoscopic ultrasound-guided placement of plastic pigtail stents for the drainage of refractory malignant ascites.

Impact of dysfunction of the facial nerve after superficial parotidectomy: a prospective study.

Letter by Castilla-Guerra et al Regarding Article, "Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis".

Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients

Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma.

PCSK9 inhibitors: A new era in stroke prevention?

Pioglitazone: Good news for diabetic patients with stroke?

Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients

Which antihypertensive drug should be used in patients with cerebrovascular disease to prevent a new stroke?